879 related articles for article (PubMed ID: 23470275)
21. Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells.
Zheng WH; Quirion R
BMC Neurosci; 2006 Jun; 7():51. PubMed ID: 16792806
[TBL] [Abstract][Full Text] [Related]
22. Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.
Svejda B; Kidd M; Kazberouk A; Lawrence B; Pfragner R; Modlin IM
Cancer; 2011 Sep; 117(18):4141-54. PubMed ID: 21387274
[TBL] [Abstract][Full Text] [Related]
23. Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways.
Salem MA; Budzyńska B; Kowalczyk J; El Sayed NS; Mansour SM
Toxicol Appl Pharmacol; 2021 Oct; 429():115697. PubMed ID: 34428446
[TBL] [Abstract][Full Text] [Related]
24. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.
Saini KS; Loi S; de Azambuja E; Metzger-Filho O; Saini ML; Ignatiadis M; Dancey JE; Piccart-Gebhart MJ
Cancer Treat Rev; 2013 Dec; 39(8):935-46. PubMed ID: 23643661
[TBL] [Abstract][Full Text] [Related]
25. PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors.
Wolin EM
Cancer Lett; 2013 Jul; 335(1):1-8. PubMed ID: 23419523
[TBL] [Abstract][Full Text] [Related]
26. Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management.
Khan KH; Wong M; Rihawi K; Bodla S; Morganstein D; Banerji U; Molife LR
Oncologist; 2016 Jul; 21(7):855-60. PubMed ID: 27151652
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation.
Riera MF; Regueira M; Galardo MN; Pellizzari EH; Meroni SB; Cigorraga SB
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E914-23. PubMed ID: 22275758
[TBL] [Abstract][Full Text] [Related]
28. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
[TBL] [Abstract][Full Text] [Related]
29. Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.
Perluigi M; Pupo G; Tramutola A; Cini C; Coccia R; Barone E; Head E; Butterfield DA; Di Domenico F
Biochim Biophys Acta; 2014 Jul; 1842(7):1144-53. PubMed ID: 24735980
[TBL] [Abstract][Full Text] [Related]
30. Targeting mTOR in mantle cell lymphoma: current and future directions.
Smith SM
Best Pract Res Clin Haematol; 2012 Jun; 25(2):175-83. PubMed ID: 22687453
[TBL] [Abstract][Full Text] [Related]
31. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF
Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361
[TBL] [Abstract][Full Text] [Related]
32. Forced, moderate-intensity treadmill exercise suppresses apoptosis by increasing the level of NGF and stimulating phosphatidylinositol 3-kinase signaling in the hippocampus of induced aging rats.
Chae CH; Kim HT
Neurochem Int; 2009 Sep; 55(4):208-13. PubMed ID: 19524110
[TBL] [Abstract][Full Text] [Related]
33. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
34. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
Zhou Q; Lui VW; Yeo W
Future Oncol; 2011 Oct; 7(10):1149-67. PubMed ID: 21992728
[TBL] [Abstract][Full Text] [Related]
35. Ameliorative effect of nicergoline on cognitive function through the PI3K/AKT signaling pathway in mouse models of Alzheimer's disease.
Zang G; Fang L; Chen L; Wang C
Mol Med Rep; 2018 May; 17(5):7293-7300. PubMed ID: 29568940
[TBL] [Abstract][Full Text] [Related]
36. PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer.
Goc A; Al-Husein B; Kochuparambil ST; Liu J; Heston WW; Somanath PR
Int J Oncol; 2011 Jan; 38(1):267-77. PubMed ID: 21109949
[TBL] [Abstract][Full Text] [Related]
37. Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease.
Leo MS; Sivamani RK
Arch Dermatol Res; 2014 Dec; 306(10):861-71. PubMed ID: 24972910
[TBL] [Abstract][Full Text] [Related]
38. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
39. Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway.
Ebrahim N; Al Saihati HA; Alali Z; Aleniz FQ; Mahmoud SYM; Badr OA; Dessouky AA; Mostafa O; Hussien NI; Farid AS; El-Sherbiny M; Salim RF; Forsyth NR; Ali FEM; Alsabeelah NF
Biomed Pharmacother; 2024 Jul; 176():116836. PubMed ID: 38850660
[TBL] [Abstract][Full Text] [Related]
40. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease.
Ahmad F; Singh K; Das D; Gowaikar R; Shaw E; Ramachandran A; Rupanagudi KV; Kommaddi RP; Bennett DA; Ravindranath V
Antioxid Redox Signal; 2017 Dec; 27(16):1269-1280. PubMed ID: 28264587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
